Silvia Mas-Peiro, Thibault Lhermusier, Marina Urena, Luis Nombela-Franco, Victoria Vilalta, Antonio Munoz-Garcia, Ignacio Amat-Santos, Felipe Atienza, Neal Kleiman, Chekrallah Chamandi, Vicenç Serra, Mark Deyell, Francisco Campelo-Parada, Pierre Mondoly, Gaspard Suc, Victoria Canadas-Godoy, Eduard Fernandez-Nofrerias, Javier Castrodeza, Jaime Elizaga, Pierre Baudinaud, Jaume Francisco Pascual, John G Webb, Emilie Pelletier-Beaumont, François Philippon, Josep Rodés-Cabau
{"title":"Late Arrhythmic Burden in Patients With Left Bundle Branch Block After TAVR With the Evolut Valve.","authors":"Silvia Mas-Peiro, Thibault Lhermusier, Marina Urena, Luis Nombela-Franco, Victoria Vilalta, Antonio Munoz-Garcia, Ignacio Amat-Santos, Felipe Atienza, Neal Kleiman, Chekrallah Chamandi, Vicenç Serra, Mark Deyell, Francisco Campelo-Parada, Pierre Mondoly, Gaspard Suc, Victoria Canadas-Godoy, Eduard Fernandez-Nofrerias, Javier Castrodeza, Jaime Elizaga, Pierre Baudinaud, Jaume Francisco Pascual, John G Webb, Emilie Pelletier-Beaumont, François Philippon, Josep Rodés-Cabau","doi":"10.1093/europace/euaf057","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Arrhythmic burden after discharge in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve replacement (TAVR) with Evolut devices remains largely unknown.</p><p><strong>Objectives: </strong>Assessing incidence and type of arrhythmias at 2-year follow-up in patients with NOP-LBBB post-TAVR.</p><p><strong>Methods: </strong>Prospective multicentre study including 88 patients with LBBB persisting for ≥3 days post-implantation. Before discharge, an implantable loop recorder (REVEAL XT/LINQ) was implanted; patients had continuous monitoring for 2 years. Arrhythmic events were adjudicated in a central core lab.</p><p><strong>Results: </strong>411 arrhythmic events were detected in 58 patients (65.9%; 2 [1-4] events per patient). Symptoms were reported in 12/58 (20.7%), and therapy was changed in 25/58 (43.1%). There were 101 bradyarrhythmic events in 33 patients (35 high grade atrioventricular block [HAVB], 66 severe bradycardia). HAVB incidence was higher in the early (4-week) phase and remained stable over time, whereas severe bradycardia increased after one year. Permanent pacemaker was required in 11 (12.5%) patients (6.8% and 5.7% in the first and second year, respectively). There were 310 tachyarrythmic events in 29 patients (120 AF/AFL, 111 AT, 72 SVT, 6 NSVT, 1 VT); its incidence decreased throughout the 2 years. New AF/AFL episodes occurred in 20/69 patients (29%; symptomatic in 2/20 [10%]).</p><p><strong>Conclusion: </strong>Patients with NOP-LBBB post-TAVR with Evolut devices exhibited a high burden of late arrhythmias, with events occurring in two thirds of patients, and leading to treatment changes in about half of them. These data should inform future studies on cardiac monitoring devices for follow-up and treatment optimization in this challenging population.</p>","PeriodicalId":11981,"journal":{"name":"Europace","volume":" ","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Europace","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/europace/euaf057","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Arrhythmic burden after discharge in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve replacement (TAVR) with Evolut devices remains largely unknown.
Objectives: Assessing incidence and type of arrhythmias at 2-year follow-up in patients with NOP-LBBB post-TAVR.
Methods: Prospective multicentre study including 88 patients with LBBB persisting for ≥3 days post-implantation. Before discharge, an implantable loop recorder (REVEAL XT/LINQ) was implanted; patients had continuous monitoring for 2 years. Arrhythmic events were adjudicated in a central core lab.
Results: 411 arrhythmic events were detected in 58 patients (65.9%; 2 [1-4] events per patient). Symptoms were reported in 12/58 (20.7%), and therapy was changed in 25/58 (43.1%). There were 101 bradyarrhythmic events in 33 patients (35 high grade atrioventricular block [HAVB], 66 severe bradycardia). HAVB incidence was higher in the early (4-week) phase and remained stable over time, whereas severe bradycardia increased after one year. Permanent pacemaker was required in 11 (12.5%) patients (6.8% and 5.7% in the first and second year, respectively). There were 310 tachyarrythmic events in 29 patients (120 AF/AFL, 111 AT, 72 SVT, 6 NSVT, 1 VT); its incidence decreased throughout the 2 years. New AF/AFL episodes occurred in 20/69 patients (29%; symptomatic in 2/20 [10%]).
Conclusion: Patients with NOP-LBBB post-TAVR with Evolut devices exhibited a high burden of late arrhythmias, with events occurring in two thirds of patients, and leading to treatment changes in about half of them. These data should inform future studies on cardiac monitoring devices for follow-up and treatment optimization in this challenging population.
期刊介绍:
EP - Europace - European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association of the European Society of Cardiology. The journal aims to provide an avenue of communication of top quality European and international original scientific work and reviews in the fields of Arrhythmias, Pacing and Cellular Electrophysiology. The Journal offers the reader a collection of contemporary original peer-reviewed papers, invited papers and editorial comments together with book reviews and correspondence.